The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 07, 2024
Filed:
Feb. 11, 2019
Applicant:
Anji Pharmaceuticals Inc., Cambridge, MA (US);
Inventors:
Alain D. Baron, San Diego, CA (US);
Mark S. Fineman, San Diego, CA (US);
Nigel R. A. Beeley, Solana Beach, CA (US);
Assignee:
Anji Pharmaceuticals Inc., Cambridge, MA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/155 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 9/24 (2006.01); A61K 9/28 (2006.01); A61K 9/48 (2006.01); A61K 31/19 (2006.01); A61K 31/198 (2006.01); A61K 31/7016 (2006.01); A61K 31/704 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/155 (2013.01); A61K 9/0053 (2013.01); A61K 9/2054 (2013.01); A61K 9/209 (2013.01); A61K 9/2846 (2013.01); A61K 9/4808 (2013.01); A61K 31/19 (2013.01); A61K 31/198 (2013.01); A61K 31/7016 (2013.01); A61K 31/704 (2013.01); A61K 45/06 (2013.01);
Abstract
Methods for improving the gastrointestinal tolerability of biguanide compounds and for treating metabolic disorders and/or inducing weight loss in patients in need thereof, particularly in individuals having a contraindication for treatment with biguanide compounds, are provided comprising administering delayed release formulations of such biguanide compounds, including metformin, targeted to the small intestine.